Identification of thiols and glutathione conjugates of depsipeptide FK228 (FR901228), a novel histone protein deacetylase inhibitor, in the blood

被引:28
|
作者
Xiao, JJ
Byrd, J
Marcucci, G
Grever, M
Chan, KK [1 ]
机构
[1] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Med & Publ Hlth, Columbus, OH 43210 USA
[3] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
关键词
D O I
10.1002/rcm.976
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Four glutathione (GSH) conjugates and two thiols were detected when depsipeptide FK228, formerly FR901228, a naturally occurring potent histone deacetylase (HDAC) inhibitor, was incubated in rat or human plasma in the presence of GSH. Their structures were elucidated by the high-performance liquid chromatography/electrospray ionization multi-stage mass spectrometry (HPLC/ESI-MSn) technique, and in some cases confirmed by accurate mass measurement. These products were also detected in rat and human blood homogenates following their incubation with FK228, but were not detected in GSH solution alone. A possible scheme for its formation is proposed. One of the thiols has recently been found to be more active as a histone deacetylase inhibitor than the parent compound. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:757 / 766
页数:10
相关论文
共 50 条
  • [41] Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of Bax, which is enhanced by the proteasome inhibitor bortezomib
    Sutheesophon, K
    Kobayashi, Y
    Takatoku, MA
    Ozawa, K
    Kano, Y
    Ishii, H
    Furukawa, Y
    ACTA HAEMATOLOGICA, 2006, 115 (1-2) : 78 - 90
  • [42] Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer
    Murakami, J
    Asaumi, J
    Kawai, N
    Tsujigiwa, H
    Yanagi, Y
    Nagatsuka, H
    Inoue, T
    Kokeguchi, S
    Kawasaki, S
    Kuroda, M
    Tanaka, N
    Matsubara, N
    Kishi, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (01) : 22 - 28
  • [43] Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report
    Piekarz, RL
    Robey, R
    Sandor, V
    Bakke, S
    Wilson, WH
    Dahmoush, L
    Kingma, DM
    Turner, ML
    Altemus, R
    Bates, SE
    BLOOD, 2001, 98 (09) : 2865 - 2868
  • [44] Involvement of the tumor necrosis factor (TNF)/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228)
    Sutheesophon, K
    Nishimura, N
    Kobayashi, Y
    Furukawa, Y
    Kawano, M
    Itoh, K
    Kano, Y
    Ishii, H
    Furukawa, Y
    JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 203 (02) : 387 - 397
  • [45] Involvement of the tumor necrosis factor (TNF)/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228).
    Sutheesophon, K
    Nishimura, N
    Furukawa, Y
    Ishii, H
    Kano, Y
    Kawano, M
    Ito, K
    Furukawa, Y
    BLOOD, 2003, 102 (11) : 595A - 595A
  • [46] The histone deacetylase inhibitor FK228 preferentially enhances adenovirus transgene expression in malignant cells
    Goldsmith, ME
    Kitazono, M
    Fok, P
    Aikou, T
    Bates, S
    Fojo, T
    CLINICAL CANCER RESEARCH, 2003, 9 (14) : 5394 - 5401
  • [47] Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivo
    Ito, T
    Ouchida, M
    Morimoto, Y
    Yoshida, A
    Jitsumori, Y
    Ozaki, T
    Sonobe, H
    Inoue, H
    Shimizu, K
    CANCER LETTERS, 2005, 224 (02) : 311 - 319
  • [48] Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of bax, which is enhanced by proteasome inhibitor bortezomib.
    Sutheesophon, K
    Kobayashi, Y
    Takatoku, MA
    Ozawa, K
    Kano, Y
    Ishii, H
    Furukawa, Y
    BLOOD, 2005, 106 (11) : 192B - 192B
  • [49] FR901228, a novel histone deacetylase inhibitor, induces cell cycle arrest and subsequent apoptosis in refractory human pancreatic cancer cells
    Sato, N
    Ohta, T
    Kitagawa, H
    Kayahara, M
    Ninomiya, I
    Fushida, S
    Fujimura, T
    Nishimura, G
    Shimizu, K
    Miwa, K
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 24 (03) : 679 - 685
  • [50] Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo
    Sasakawa, Y
    Naoe, Y
    Inoue, T
    Sasakawa, T
    Matsuo, M
    Manda, T
    Mutoh, S
    BIOCHEMICAL PHARMACOLOGY, 2002, 64 (07) : 1079 - 1090